Literature DB >> 12351357

FDA fails to reduce accessibility of paracetamol despite 450 deaths a year.

Ray Moynihan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12351357      PMCID： PMC1124220          DOI： 10.1136/bmj.325.7366.678

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Pharmacological treatments for persistent non-malignant pain in older persons.

Authors:  Thorsten Nikolaus; Andrej Zeyfang
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

2.  NQO2 is a reactive oxygen species generating off-target for acetaminophen.

Authors:  Teemu P Miettinen; Mikael Björklund
Journal:  Mol Pharm       Date:  2014-10-24       Impact factor: 4.939

3.  BGP-15 Protects Mitochondria in Acute, Acetaminophen Overdose Induced Liver Injury.

Authors:  Farkas Sarnyai; Timea Szekerczés; Miklós Csala; Balázs Sümegi; András Szarka; Zsuzsa Schaff; József Mandl
Journal:  Pathol Oncol Res       Date:  2019-11-08       Impact factor: 3.201

4.  Using the simulated patient methodology to assess paracetamol-related counselling for headache.

Authors:  Nejc Horvat; Marko Koder; Mitja Kos
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

5.  Intraocular pressure-lowering effect of oral paracetamol and its in vitro corneal penetration properties.

Authors:  Nabiel Mohamed; David Meyer
Journal:  Clin Ophthalmol       Date:  2013-01-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.